Global Medical Biliary Stent Market Strategic Research Report

Scope of the Report

The global Medical Biliary Stent market size is predicted to grow from US$ 640 million in 2025 to US$ 968 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

A medical biliary stent is a tubular device, made of polymer, metal, or a combination of both, that is inserted into the biliary duct to maintain ductal patency and ensure bile drainage in patients with biliary obstruction. It is used to manage both benign and malignant strictures, prevent or relieve cholestasis, and facilitate minimally invasive endoscopic or percutaneous procedures. Medical biliary stents vary in design, material, diameter, length, and delivery system, depending on the clinical scenario and intended duration of placement. In 2024, global sales of medical biliary stents reached 1,235,890 units, with an average selling price of US$498.0 per unit. The single-line production capacity of biliary stents is approximately 10,000 units per year, with a gross profit margin of approximately 50%–75%.

The medical biliary stent industry chain encompasses three major segments: upstream raw material supply, midstream manufacturing and processing, and downstream clinical application. The upstream segment includes suppliers of key raw materials and technologies such as medical polymers (e.g., polyethylene, polyurethane, PTFE), metal materials (stainless steel, nickel-titanium alloy), composite materials, and anti-biofilm coatings, drug eluents, radiopaque markers, and sterilization packaging. These provide fundamental guarantees for the stent's mechanical properties, biocompatibility, anti-blockage performance, and imaging visualization. The midstream segment involves plastic stent extrusion or injection molding, metal stent braiding/laser cutting, surface treatment and coating, stent and delivery system assembly, performance testing, and regulatory registration. This is the core link ensuring product stability, reliability, and clinical safety. The downstream segment consists of medical device distributors, import agents, and hospital procurement systems. Clinical placement is completed through ERCP or percutaneous biliary intervention techniques, covering various indications such as benign and malignant biliary strictures and postoperative anastomotic strictures. This is supplemented by physician training, postoperative management, and after-sales service. Furthermore, factors such as medical insurance and commercial insurance coverage, hospital procurement policies, and physician usage preferences directly influence the stent's market penetration and sales performance. Overall, this industry chain demonstrates a close integration of material innovation, manufacturing processes, and clinical applications, forming a key framework supporting the stable growth of the medical biliary stent market.

The growth of the medical biliary stent market is primarily driven by factors such as the rising prevalence of biliary tract diseases, the widespread adoption of ERCP technology in hospitals, continuous optimization of materials and surface treatment processes, and the cost advantage of plastic stents in short-term drainage. Simultaneously, their routine replacement cycle of 3–6 months generates stable repeat purchase demand. However, the market also faces multiple risks, including the higher restenosis rate of plastic stents leading to the replacement of some long-term cases with metal self-expanding stents, downward pressure on prices due to global hospital procurement and the entry of low-cost competitors, potential increases in manufacturing costs due to supply chain fluctuations in medical polymers and coating materials, and stricter regulations in various countries imposing higher requirements on biocompatibility, sterilization validation, and leaching testing. Furthermore, changes in physician preferences and the technological evolution of new absorbable stents and coated metal stents may also affect the market share and clinical adoption rate of plastic biliary stents.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Biliary Stent market?

What factors are driving Medical Biliary Stent market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Biliary Stent market opportunities vary by end market size?

How does Medical Biliary Stent break out by Type, by Application?

This report presents a comprehensive overview of the global Medical Biliary Stent market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Metal Biliary Stents
• Plastic Biliary Stents

Segment by Feature

• Biodegradable Stent
• Non-biodegradable Stent

Segment by Delivery Method

• ERCP Endoscopic Delivery
• EUS-Guided Drainage Delivery
• PTBD Delivery

Segment by Application

• Hospital
• Medical Center

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Biliary Stent market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Medical Center evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact